Medical News

RSS

Porvair Sciences launches multi-format mixer for laboratory use

Porvair Sciences has introduced the Co-Mix - an accurate, reliable, compact and simple-to-use multi-format mixer.

From Porvair Sciences Limited 12 Nov 2013

University of Sydney lecture to focus on the minds of teenage girls

Imagine a classroom of normal healthy teenage girls. As many as half of them may grow up and develop anxiety and depression. But which ones will they be?

12 Nov 2013

Cellectricon introduces Dynaflow Resolve Temperature Control system for ion channel research

Cellectricon, a leading provider of advanced cell-based screening technologies and services, launches the Dynaflow Resolve Temperature Control system at Neuroscience 2013 (San Diego), booth #933.

From Cellectricon 12 Nov 2013

Hebrew University to participate in new European research project on chronic pain

The Hebrew University of Jerusalem is one of 11 universities, medical centers and research institutes in seven countries participating in ncRNAPain, a new European research project that aims at further exploring the biological mechanisms underlying chronic pain.

12 Nov 2013

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

Revalesio Corporation is pleased to announce a new collaboration with noted neurologist Dr. Roland Martin, Head of Neuroimmunology and MS Research at the Department of Neurology, University Hospital Zurich. Dr. Martin will be conducting a Phase IIa clinical trial of RNS60 in patients with relapsing-remitting multiple sclerosis.

12 Nov 2013

FDA Advisory Committee votes in favor of Cochlear Nucleus Hybrid L24 Implant System

Cochlear Limited, the global leader in implantable hearing solutions, announced today that an advisory committee to the US Food and Drug Administration voted favorably on the Cochlear Nucleus Hybrid L24 Implant System.

12 Nov 2013

Kaiser Permanente's Medicare health plan website launches new seminar search tool

Kaiser Permanente's highly rated Medicare health plan website, kp.org/medicare, has launched a new feature that is designed to help seniors find information more easily and conveniently.

12 Nov 2013

Leica Biosystems launches new Novocastra HD menu for hematopathology

Leica Biosystems announces the launch of the fourth Novocastra HD menu, focused on hematopathology. Previously launched were the Novocastra HD menus for breast, head & neck and dermatopathology.

12 Nov 2013

S2O2 finalizes acquisition of Texas-based sanitation technology innovator

Neutra Corp., a growing provider of all-natural wellness solutions, announced today that its joint venture partner Surface to Air Solutions is finalizing the acquisition of a sanitation technology innovator dedicated to greatly reducing the risk of staph infection in sports.

12 Nov 2013

ED visits associated with OTC pediatric cough cold medicines in children decline

A new study, "Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision," shows that emergency department visits associated with over-the-counter pediatric cough cold medicines in children age 3 and younger have declined following voluntary industry labeling initiatives specifically designed to improve safe use in this age.

12 Nov 2013

BioGaia plans to invest in first phase of project aimed at developing drug for NEC

The board of BioGaia has decided to invest in the first phase of a long-term project aimed at developing a drug with rigorous hygiene, analysis and documentation requirements, to treat the highly fatal disease Necrotising Enterocolitis, which affects premature infants.

12 Nov 2013

Nontoxic therapy shows encouraging results in blood samples from lupus patients

Northwestern Medicine- scientists have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease.

12 Nov 2013

Study provides new evidence underlining the significance of bitter taste perception

It's no coincidence that the expression "to leave a bitter taste in one's mouth" has a double meaning; people often have strong negative reactions to bitter substances, which, though found in healthful foods like vegetables, can also signify toxicity. For this reason, the ability to sense bitterness likely played an important role in human evolution.

12 Nov 2013

Researchers look to animal models to better understand human brain function, vision loss

Research released today reveals a new model for a genetic eye disease, and shows how animal models - from fruit flies to armadillos and monkeys - can yield valuable information about the human brain. The findings were presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

12 Nov 2013

Shield Therapeutics files IND application with FDA to initiate ST10 Phase 3 study

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.

12 Nov 2013

Australian scientists unravel mystery behind immune system memory

While the principle of immune memory has been known for decades, the exact molecular mechanisms underpinning it have remained a mystery. Australian scientists have now unraveled part of that mystery, identifying the role of a gene called STAT3, which acts as a kind of roundabout, directing chemical messenger molecules to various destinations.

12 Nov 2013

Zients warned years ago about problems with federal IT; Obama administration turning to insurers' expertise for website difficulties

Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).

12 Nov 2013

Peripheral prism glasses provide simple mobility rehabilitation intervention for hemianopia

More than a million Americans suffer from hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma. People with hemianopia frequently bump into walls, trip over objects, or walk into people on the side where the visual field is missing.

12 Nov 2013

New study stresses importance of studying freezing episodes in Parkinson's patients

A recent study, led by Ryan P. Duncan of Washington University at St. Louis, suggested patients with Parkinson's disease who suffer from freezing episodes are more likely to have impaired balance than those who do not. This is an important discovery as Parkinson's disease typically develops in elderly patients, who cannot afford to be unstable, lose balance and potentially fall, which could result in major injuries.

12 Nov 2013

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Swiss-based Helsinn group has granted Chugai Pharma Marketing Ltd., a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd., exclusive commercialization rights to their innovative ghrelin receptor agonist, anamorelin, for the three major European pharma markets.

12 Nov 2013

Medical News

Porvair Sciences launches multi-format mixer for laboratory use

University of Sydney lecture to focus on the minds of teenage girls

Cellectricon introduces Dynaflow Resolve Temperature Control system for ion channel research

Hebrew University to participate in new European research project on chronic pain

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

FDA Advisory Committee votes in favor of Cochlear Nucleus Hybrid L24 Implant System

Kaiser Permanente's Medicare health plan website launches new seminar search tool

Leica Biosystems launches new Novocastra HD menu for hematopathology

S2O2 finalizes acquisition of Texas-based sanitation technology innovator

ED visits associated with OTC pediatric cough cold medicines in children decline

BioGaia plans to invest in first phase of project aimed at developing drug for NEC

Nontoxic therapy shows encouraging results in blood samples from lupus patients

Study provides new evidence underlining the significance of bitter taste perception

Researchers look to animal models to better understand human brain function, vision loss

Shield Therapeutics files IND application with FDA to initiate ST10 Phase 3 study

Australian scientists unravel mystery behind immune system memory

Zients warned years ago about problems with federal IT; Obama administration turning to insurers' expertise for website difficulties

Peripheral prism glasses provide simple mobility rehabilitation intervention for hemianopia

New study stresses importance of studying freezing episodes in Parkinson's patients

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News